Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2546416017 | Fosamprenavir 50mg/mL oral suspension (product) | en | Fully specified name | Inactive | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 2548709010 | Fosamprenavir 50mg/mL oral suspension | en | Synonym (core metadata concept) | Inactive | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 3693280012 | Fosamprenavir (as fosamprenavir calcium) 50 mg/mL oral suspension | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 3693281011 | Product containing precisely fosamprenavir (as fosamprenavir calcium) 50 milligram/1 milliliter conventional release oral suspension (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3693282016 | Product containing precisely fosamprenavir (as fosamprenavir calcium) 50 milligram/1 milliliter conventional release oral suspension | en | Synonym (core metadata concept) | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Fosamprenavir (as fosamprenavir calcium) 50 mg/mL oral suspension | Is a | Product containing fosamprenavir (medicinal product) | false | Inferred relationship | Some | ||
| Fosamprenavir (as fosamprenavir calcium) 50 mg/mL oral suspension | Has manufactured dose form | Oral suspension | true | Inferred relationship | Some | ||
| Fosamprenavir (as fosamprenavir calcium) 50 mg/mL oral suspension | Has active ingredient | Fosamprenavir (substance) | false | Inferred relationship | Some | ||
| Fosamprenavir (as fosamprenavir calcium) 50 mg/mL oral suspension | Is a | Product manufactured as oral dose form (product) | false | Inferred relationship | Some | ||
| Fosamprenavir (as fosamprenavir calcium) 50 mg/mL oral suspension | Is a | Product containing fosamprenavir in oral dose form (medicinal product form) | false | Inferred relationship | Some | ||
| Fosamprenavir (as fosamprenavir calcium) 50 mg/mL oral suspension | Has basis of strength substance (attribute) | Fosamprenavir (substance) | true | Inferred relationship | Some | 1 | |
| Fosamprenavir (as fosamprenavir calcium) 50 mg/mL oral suspension | Has precise active ingredient | Fosamprenavir calcium (substance) | true | Inferred relationship | Some | 1 | |
| Fosamprenavir (as fosamprenavir calcium) 50 mg/mL oral suspension | Has concentration strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
| Fosamprenavir (as fosamprenavir calcium) 50 mg/mL oral suspension | Count of base of active ingredient | 1 (kwalificatiewaarde) | false | Inferred relationship | Some | ||
| Fosamprenavir (as fosamprenavir calcium) 50 mg/mL oral suspension | Has concentration strength denominator unit | mL | true | Inferred relationship | Some | 1 | |
| Fosamprenavir (as fosamprenavir calcium) 50 mg/mL oral suspension | Has concentration strength denominator value | 1 (kwalificatiewaarde) | false | Inferred relationship | Some | 1 | |
| Fosamprenavir (as fosamprenavir calcium) 50 mg/mL oral suspension | Has concentration strength numerator value | 50 (kwalificatiewaarde) | false | Inferred relationship | Some | 1 | |
| Fosamprenavir (as fosamprenavir calcium) 50 mg/mL oral suspension | Is a | Fosamprenavir only product in oral dose form | true | Inferred relationship | Some | ||
| Fosamprenavir (as fosamprenavir calcium) 50 mg/mL oral suspension | Plays role | Antiretroviral therapeutic role | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR